Baird’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-7,053
Closed -$654K 1380
2014
Q4
$654K Buy
7,053
+59
+0.8% +$5.47K 0.01% 862
2014
Q3
$481K Buy
6,994
+1,135
+19% +$78.1K 0.01% 842
2014
Q2
$614K Buy
+5,859
New +$614K 0.01% 787